Select Medical Holdings Corporation

NYSE
SEM
Stock
Yield per half year: -21.57%
Dividend yield: 1.6%
Sector: Healthcare

Company Analysis Select Medical Holdings Corporation

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (12.4 $) is less than fair price (17.39 $)
  • Dividends (1.6%) are higher than the sector average (1.3%).
  • Current debt level 48.22% is below 100% and has decreased over 5 years from 61.44%.
  • The company's current efficiency (ROE=14.41%) is higher than the sector average (ROE=-73.65%)

Disadvantages

  • The stock's return over the last year (-37.79%) is lower than the sector average (-9.46%).

Similar companies

Bristol-Myers

Humana

UnitedHealth Group

PFIZER

2. Share price and performance

2.1. Share price

2.3. Market efficiency

Select Medical Holdings Corporation Healthcare Index
7 days 2.7% -0.6% -0.6%
90 days -19.9% -4% 7.9%
1 year -37.8% -9.5% 14.5%

SEM vs Sector: Select Medical Holdings Corporation has significantly underperformed the "Healthcare" sector by -28.33% over the past year.

SEM vs Market: Select Medical Holdings Corporation has significantly underperformed the market by -52.3% over the past year.

Stable price: SEM is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: SEM with weekly volatility of -0.7267% over the past year.

3. Summary of the report

3.1. General

P/E: 10.95
P/S: 0.4516

3.2. Revenue

EPS 1.72
ROE 14.41%
ROA 3.22%
ROIC 7.46%
Ebitda margin 9.84%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (12.4 $) is lower than the fair price (17.39 $).

Price significantly below the fair price: The current price (12.4 $) is 40.2% lower than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (10.95) is lower than that of the sector as a whole (29.26).

P/E vs Market: The company's P/E (10.95) is lower than that of the market as a whole (52.32).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.17) is lower than that of the sector as a whole (10.48).

P/BV vs Market: The company's P/BV (1.17) is lower than that of the market as a whole (18.5).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.4516) is lower than that of the sector as a whole (3.99).

P/S vs Market: The company's P/S indicator (0.4516) is lower than that of the market as a whole (27.95).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (9.77) is lower than that of the sector as a whole (18.36).

EV/Ebitda vs Market: The company's EV/Ebitda (9.77) is lower than that of the market as a whole (37.43).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -3.47% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-3.47%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.3%).

5.4. ROE

ROE vs Sector: The company's ROE (14.41%) is higher than that of the sector as a whole (-73.65%).

ROE vs Market: The company's ROE (14.41%) is lower than that of the market as a whole (36.05%).

5.5. ROA

ROA vs Sector: The company's ROA (3.22%) is lower than that of the sector as a whole (6.71%).

ROA vs Market: The company's ROA (3.22%) is lower than that of the market as a whole (11.45%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (7.46%) is lower than that of the sector as a whole (21.56%).

ROIC vs Market: The company's ROIC (7.46%) is lower than that of the market as a whole (10.19%).

6. Finance

6.1. Assets and debt

Debt level: (48.22%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 61.44% to 48.22%.

Excess of debt: The debt is not covered by net income, percentage 1263.49%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 1.6% is higher than the average for the sector '1.3%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 1.6% has been steadily paid over the past 7 years, DSI=0.79.

Weak dividend growth: The company's dividend yield 1.6% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (30.19%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Select Medical Holdings Corporation

9.3. Comments